With WSO and ICAAA, we reported 5 rilevant practical areas: 1. diagnosis, testing, prediction of ICH risk; 2. antithrombotic agents and vascular interventions; 3. vascular risk factors and medications; 4. CAA treatment; 5. diagnosis and treatment of CAA-ri https://t.co/1WkznP1QQb
Drug-Induced Amyloid-Related Imaging Abnormalities: A Neurovascular Perspective on Risk Assessment https://t.co/gTIXXVmgIM
NEW MANUSCRIPT: through neurovascular lens, we highlighted how cerebrovascular comorbidity and CAA influences risk and severity of drug-induced ARIA.
Explore latest insights on ARIA and CAA in AAT, focusing on:
Antibody-driven amplification of CAA-related inflammation (CAA-ri)
The ARIA Paradox
Emerging Biomarkers reshaping the pathophysiological interpretation of ARIA
Therapeutic opportunities
Safety monitoring strategies
๐จ PIA Group Webinar Alert ๐จ
๐ฅ๐ฒ๐๐ต๐ถ๐ป๐ธ๐ถ๐ป๐ด ๐๐ฅ๐๐: Antibody Amplified CAA-ri?
๐ Friday, April 24, 2026
โฐ 9:00 a.m. C.T.
๐ก Join our V-PIA and
donโt miss this opportunity to learn from experts and engage in cutting-edge discussion.
https://t.co/hGV3Ll0jpY
The VCID Clinical Trials work group of the Vascular Cognitive Disorders PIA's The Basics webinar is set for March 10.
Registration link:ย ย https://t.co/jwei5rqRZt
Become a member of ISTAART Vascular PIA and be part of the new activities we are planning!
https://t.co/5Hst4Zx6bo
#Microbiota-gut-brain axis dysregulation in #Alzheimerโs disease and its modulation through #probiotic supplementation
Fresh new published, congrats to Moira Marizzoni and many thanks to Prof. Annamaria Cattaneo and team!
@iCABNetwork@alzassociation
https://t.co/qo4TNP0CTq
#Donanemab receives positive opinion from the European Medicine Agency Committee for Medicinal Products for Human Use (CHMP) in early symptomatic #Alzheimers disease.
https://t.co/bzJNe1oUN8
Cracking the code of cerebral amyloid angiopathy in AD.
- Neuropathology of CAA and Its Comorbidity with AD (Prof. Jaunmuktane Z)
- Rethinking ARIA in Alzheimerโs Immunotherapy: Iatrogenic CAA-ri. (Prof. Piazza F)
online. Jun 13, 2025 at 4:30pm (CEST)
https://t.co/uHuAWKMhdb
#Hemostasis components in cerebral #amyloid angiopathy and #Alzheimer disease
Contribution of hemostasis components to Aฮฒ deposition, endothelial and BBB dysfunction, vessel fragility, cerebral bleeding, and cognitive changes.
https://t.co/bsPdBxAmXD
#donanemab#lecanemab
Cracking the code of cerebral amyloid angiopathy in AD.
- Neuropathology of CAA and Its Comorbidity with AD (Prof. Jaunmuktane Z)
- Rethinking ARIA in Alzheimerโs Immunotherapy: Iatrogenic CAA-ri. (Prof. Piazza F)
online. Jun 13, 2025 at 4:30pm (CEST)
https://t.co/uHuAWKMhdb
Clinical and Neuroradiological Manifestations of Cerebral Amyloid Angiopathy: A Closer Look into the Natural History of a Frequent Disease https://t.co/DZIBMQ1EOj #mdpijcm
Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy?
https://t.co/whXVjc8cvN #mdpibiomedicines